1. Home
  2. STRA vs NKTR Comparison

STRA vs NKTR Comparison

Compare STRA & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$80.63

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$71.97

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
NKTR
Founded
2017
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
STRA
NKTR
Price
$80.63
$71.97
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$96.50
$142.00
AVG Volume (30 Days)
318.0K
809.7K
Earning Date
04-23-2026
03-12-2026
Dividend Yield
2.96%
N/A
EPS Growth
15.85
N/A
EPS
5.41
N/A
Revenue
$997,137,000.00
$307,711,000.00
Revenue This Year
$3.93
N/A
Revenue Next Year
$4.93
N/A
P/E Ratio
$14.95
N/A
Revenue Growth
57.23
86.00
52 Week Low
$72.17
$0.43
52 Week High
$92.98
$77.00

Technical Indicators

Market Signals
Indicator
STRA
NKTR
Relative Strength Index (RSI) 49.83 58.69
Support Level $78.87 $52.99
Resistance Level $82.77 $75.96
Average True Range (ATR) 2.69 3.97
MACD 0.01 -0.72
Stochastic Oscillator 34.92 57.52

Price Performance

Historical Comparison
STRA
NKTR

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Share on Social Networks: